Tekmira Pharmaceuticals Corp (NASDAQ:TKMR)

18.17
Delayed Data
As of Feb 27
 -0.22 / -1.20%
Today’s Change
8.86
Today|||52-Week Range
31.48
+19.93%
Year-to-Date
No recent news for Tekmira Pharmaceuticals Corp.

Today’s Trading

Previous close18.39
Today’s open18.21
Day’s range17.50 - 18.32
Volume836,283
Average volume (3 months)981,519
Market cap$405.4M
Dividend yield--
Data as of 4:00pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)-142.38%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+9.58%
P/E ratio--
Price/Sales7.87
Price/Book5.85

Competitors

 Today’s
change
Today’s
% change
SPPISpectrum Pharmaceuti...+0.04+0.65%
PTXPernix Therapeutics ...-0.17-1.56%
DERMDermira Inc-1.17-6.54%
SCLNSciClone Pharmaceuti...0.000.00%
Data as of 4:00pm ET, 02/27/2015

Financials

Next reporting dateMarch 18, 2015
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$15.5M
Annual profit (last year)-$14.1M
Net profit margin-90.95%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Financial Officer &
Executive Vice President
Bruce G. Cousins
Corporate headquarters
Burnaby, British Columbia

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account